Atlas Trials

Progression Free Survival

28 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Progression Free Survival

RecordFirmDate
HRD and Resistance to PAPPi in EOC Patients (NCT05310370)Lei Li2022-03-26
Chromosomal Instability in Ovarian Cancer (NCT05310357)Lei Li2022-03-26
PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer (NCT05310305)Lei Li2022-03-26
Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors (NCT04933669)First Affiliated Hospital of Zhejiang University2021-09-07
Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma (NCT04664244)Lei Li2020-12-19
Efficacy of Postoperative Radiotherapy for Atypical Meningioma Without Venous Sinus Invasion After Gross-total Resection (NCT04127760)Second Affiliated Hospital, Zhejiang University, School of Medicine2020-01-01
Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer (NCT04101760)Lei Li2019-10-01
IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer (NCT03748680)Karen-Lise Garm Spindler2018-10-01
Apatinib Plus Anti-PD1 Therapy for Advanced Osteosarcoma (NCT03359018)Peking University People's Hospital2018-01-01
Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma (NCT03342300)Peking University People's Hospital2017-11-06
Real-world Study for Patients With Advanced Hepatobiliary Tumors (NCT03892577)Peking Union Medical College Hospital2017-07-01
A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer (NCT03100955)Qingdao University2017-03-01
Clinical Study on Triple Negative Breast Cancer With Chinese Medicine (NCT03332368)Sheng Liu2017-01-01
Maintenance Therapy for Small-cell Lung Cancer (NCT03769935)Qingdao Central Hospital2017-01-01
Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer (NCT02959749)Qingdao Central Hospital2015-08-01
Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI) (NCT00944918)AstraZeneca2008-12-01
Microwave Ablation Versus Laparoscopic Hepatectomy for 3-5cm Hepatocellular Carcinoma (NCT05796700)Chinese PLA General Hospital2008-01-01

Track Progression Free Survival automatically

Every clearance here is in the API, with alerts when new ones post.